NCI-H596

The NCI-H596 cell line is derived from a human adenosquamous carcinoma of the lung. This unique cell line is used extensively in lung cancer research, providing a model to study the characteristics and behavior of adenosquamous carcinoma, a rare subtype of non-small cell lung cancer that exhibits features of both adenocarcinoma and squamous cell carcinoma. The NCI-H596 cell line is valuable for investigating the molecular and genetic underpinnings of this hybrid cancer type, as well as for testing potential therapeutic interventions.

NCI-H596 cells exhibit an epithelial morphology and express markers indicative of both adenocarcinoma and squamous cell carcinoma, including cytokeratins and mucin proteins. They harbor genetic alterations common in lung cancer, such as mutations in the KRAS and TP53 genes, which are pivotal in cell signaling, growth, and apoptosis. Researchers utilize NCI-H596 cells to explore the signaling pathways involved in tumor progression, such as the EGFR, MAPK, and PI3K/Akt pathways. These cells are also employed in drug discovery and development, allowing for the evaluation of chemotherapeutic agents, targeted therapies, and novel treatment combinations. The NCI-H596 cell line's dual histological features make it a critical tool for understanding the complexities of adenosquamous carcinoma and for advancing therapeutic strategies in lung cancer treatment.

37°C, 5% CO₂, humidified atmosphere.

1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.

For full details, please refer to our Warranty Statement.